<html>
<head>PUBMED IDs for GALNT14</head>
<body bgcolor='#C5F0F2'><h1>GALNT14</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23959947/'>A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.</a> February 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24962947/'>GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24962896/'>Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.</a> February 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25975956/'>Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients.</a> February 26  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26309160/'>Identification of GALNT14 as a novel neuroblastoma predisposition gene.</a> July 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27124048/'>GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.</a> January 31  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27133078/'>MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.</a> February 1  2016<br></body></html>
